Sentry Investment Management LLC Decreases Stake in Zoetis Inc. (NYSE:ZTS)

Sentry Investment Management LLC cut its position in Zoetis Inc. (NYSE:ZTS) by 10.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,152 shares of the company’s stock after selling 262 shares during the period. Sentry Investment Management LLC’s holdings in Zoetis were worth $373,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. increased its holdings in Zoetis by 1.0% in the first quarter. Vanguard Group Inc. now owns 40,749,571 shares of the company’s stock valued at $6,895,235,000 after buying an additional 414,605 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Zoetis by 31.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after acquiring an additional 3,244,074 shares during the last quarter. Capital World Investors raised its position in shares of Zoetis by 0.6% during the 4th quarter. Capital World Investors now owns 9,064,158 shares of the company’s stock worth $1,788,988,000 after acquiring an additional 57,798 shares in the last quarter. Norges Bank acquired a new stake in shares of Zoetis during the 4th quarter worth about $980,646,000. Finally, Bank of New York Mellon Corp lifted its stake in Zoetis by 4.0% during the second quarter. Bank of New York Mellon Corp now owns 4,687,902 shares of the company’s stock worth $812,695,000 after purchasing an additional 178,303 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have weighed in on ZTS shares. Stifel Nicolaus reissued a “buy” rating and set a $200.00 price objective on shares of Zoetis in a report on Tuesday, August 27th. BTIG Research lifted their target price on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Piper Sandler upped their target price on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Finally, Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $217.11.

Zoetis Trading Down 0.7 %

NYSE:ZTS opened at $189.99 on Thursday. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. The stock’s 50 day simple moving average is $182.22 and its 200-day simple moving average is $174.42. The firm has a market cap of $86.07 billion, a P/E ratio of 36.61, a PEG ratio of 2.90 and a beta of 0.88.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. The company had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. Zoetis’s quarterly revenue was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.41 EPS. Equities analysts anticipate that Zoetis Inc. will post 5.84 EPS for the current year.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.